SpectraCure publicerar investerarbrev

SpectraCure publicerar ett investerarbrev bifogat i pressmeddelandet samt på sin webbplats www.spectracure.se.

I investerarbrevet ges svar på några vanliga frågor samt en kortfattad beskrivning av arbetet med den kliniska studien.

This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.